drugset / Trial / NCT00852046
Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement
RandomizedParallel-groupTriple-blindTreatment
Summary
Assess impact of increasing dose of dexmedetomidine on total daily dose of fentanyl and propofol while maintaining sedation in a mechanically ventilated patient in a general medical intensive care unit.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Outcome
Outcome not reported
Stopped: “PI resigned.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.6 ug/kg | Intravenous |
Indications
No indication recorded.